Engineered T cells expressing the T1E28z CAR, an ErbB ligand fused to CD28 and CD3, will be delivered directly by injection into tumors of HNSCC patients with locoregional disease22. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.